Emine Gulsah Torun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Emine Gulsah Torun has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
İbRahim Ece
Ministry of Health Ankara Bilkent City Hospital
6 shared publications- Mutlu Uysal Yazıcı
Division of Pediatric Critical Care, Department of Pediatrics, Gazi University Faculty of Medicine, Ankara, Türkiye
5 shared publications - Nevin Özdemiroğlu
Ankara Bilkent City Hospital
5 shared publications - Serhat Koca
Department of Pediatric Cardiology, Ankara Bilkent City Hospital, Ankara, Türkiye
5 shared publications - Denizhan Bagrul
Department of Pediatric Cardiology, Ankara Bilkent City Hospital, Children Hospital, Ankara, Türkiye
4 shared publications - Aysegul Ertugrul
Department of Pediatric Allergy and Immunology Ankara Etlik City Hospital Ankara Turkey
3 shared publications
Latest Publications
- 3 November 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- p. 1-3
Transcatheter ventricular septal shunt creation in end-stage paediatric pulmonary arterial hypertension: lessons from a rescue decompression strategy
A 12-year-old girl with end-stage suprasystemic pulmonary arterial hypertension and progressive right ventricular failure underwent transcatheter ventricular septal shunt creation after deterioration despite targeted therapy and prior atrial septostomy. Right-to-left shunting was established, but haemodynamic improvement was limited; pulmonary pressures remained suprasystemic, persistent pericardial effusion developed, and the patient died despite intensive treatment, illustrating the complexity of rescue decompression in advanced disease.
- 3 November 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- p. 1-3
Transcatheter ventricular septal shunt creation in end-stage paediatric pulmonary arterial hypertension: lessons from a rescue decompression strategy
A 12-year-old girl with end-stage suprasystemic pulmonary arterial hypertension and progressive right ventricular failure underwent transcatheter ventricular septal shunt creation after deterioration despite targeted therapy and prior atrial septostomy. Right-to-left shunting was established, but haemodynamic improvement was limited; pulmonary pressures remained suprasystemic, persistent pericardial effusion developed, and the patient died despite intensive treatment, illustrating the complexity of rescue decompression in advanced disease.
- 28 September 2026
- Published by Wiley in Pacing and Clinical Electrophysiology
Multiple Accessory Pathways in Children: Electrophysiological Features and Catheter Ablation Outcomes
Background: Multiple accessory pathways (MAPs) may complicate electrophysiological assessment and catheter ablation in pediatric patients. We aimed to evaluate the clinical and electrophysiological characteristics, anatomical distribution, and procedural and follow‐up outcomes of pediatric patients with MAPs. Materials and Methods: This retrospective study included pediatric patients with at least two distinct accessory pathways identified during EPS between November 2019 and February 2026. Results: Of 1101 patients who underwent catheter ablation, 619 had accessory pathway–related arrhythmias; among these, 31 (5.0%) had MAPs. The mean age and body weight at the first procedure were 12.1 ± 3.6 years and 44.2 ± 18.8 kg, respectively, and 16 patients were female. Nine patients had structural heart disease, including seven with Ebstein anomaly. A total of 66 accessory pathways were identified: 28 patients had two pathways, two had three, and one had four. The right posteroseptal region was the most common pathway location (27.3%). One patient also had atrioventricular nodal reentrant tachycardia. Complete elimination of all accessory pathways was achieved in 29 of 31 patients (93.5%), and 63 of 66 pathways (95.5%) were successfully ablated. Recurrence occurred in six patients (19.4%). No procedure‐related complications were observed during a mean follow‐up of 26.3 ± 18.7 months. Conclusion: MAPs were successfully treated with high acute success rates and no procedure‐related complications. Nevertheless, recurrence and the identification of additional accessory pathways during subsequent evaluations remained clinically relevant, supporting the need for systematic post‐ablation reassessment and long‐term follow‐up.
- 28 September 2026
- Published by Wiley in Pacing and Clinical Electrophysiology
Multiple Accessory Pathways in Children: Electrophysiological Features and Catheter Ablation Outcomes
Background: Multiple accessory pathways (MAPs) may complicate electrophysiological assessment and catheter ablation in pediatric patients. We aimed to evaluate the clinical and electrophysiological characteristics, anatomical distribution, and procedural and follow‐up outcomes of pediatric patients with MAPs. Materials and Methods: This retrospective study included pediatric patients with at least two distinct accessory pathways identified during EPS between November 2019 and February 2026. Results: Of 1101 patients who underwent catheter ablation, 619 had accessory pathway–related arrhythmias; among these, 31 (5.0%) had MAPs. The mean age and body weight at the first procedure were 12.1 ± 3.6 years and 44.2 ± 18.8 kg, respectively, and 16 patients were female. Nine patients had structural heart disease, including seven with Ebstein anomaly. A total of 66 accessory pathways were identified: 28 patients had two pathways, two had three, and one had four. The right posteroseptal region was the most common pathway location (27.3%). One patient also had atrioventricular nodal reentrant tachycardia. Complete elimination of all accessory pathways was achieved in 29 of 31 patients (93.5%), and 63 of 66 pathways (95.5%) were successfully ablated. Recurrence occurred in six patients (19.4%). No procedure‐related complications were observed during a mean follow‐up of 26.3 ± 18.7 months. Conclusion: MAPs were successfully treated with high acute success rates and no procedure‐related complications. Nevertheless, recurrence and the identification of additional accessory pathways during subsequent evaluations remained clinically relevant, supporting the need for systematic post‐ablation reassessment and long‐term follow‐up.
- 1 August 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (8) , 1671-1678
Ventricular electrical remodelling in children with isolated ventricular septal defects before and after closure
Background: Children with ventricular septal defects experience chronic left-to-right shunting, resulting in ventricular volume overload and alterations in myocardial electrical properties. Data on ventricular electrical remodelling following closure, particularly regarding closure technique, remain limited. Objectıve: To evaluate ventricular depolarisation and repolarisation indices in children with isolated ventricular septal defects before and after closure and to compare the outcomes of surgical and transcatheter approaches. Methods: This retrospective, single-centre study included 58 children aged 4–18 months who underwent isolated ventricular septal defect closure (transcatheter, n = 25; surgical, n = 33) and 40 age- and sex-matched healthy controls. Standard 12-lead electrocardiograms recorded before the procedure and at six months after closure were analysed. Multiple ventricular depolarisation and repolarisation indices were assessed. Results: Before closure, children with ventricular septal defects demonstrated significant abnormalities in ventricular depolarisation and repolarisation indices compared with healthy controls (all p < 0.05). Following closure, most repolarisation indices improved in both groups. Improvement was more pronounced after transcatheter closure, whereas QT interval and QT dispersion did not significantly improve following surgical closure. At the six-month follow-up, QRS duration remained significantly longer in both interventions than in controls. Conclusion: Children with isolated ventricular septal defects demonstrate subclinical alterations in ventricular depolarisation and repolarisation. Defect closure is associated with substantial improvement in ventricular repolarisation; however, depolarisation abnormalities may persist during mid-term follow-up irrespective of closure technique.
- 1 August 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (8) , 1671-1678
Ventricular electrical remodelling in children with isolated ventricular septal defects before and after closure
Background: Children with ventricular septal defects experience chronic left-to-right shunting, resulting in ventricular volume overload and alterations in myocardial electrical properties. Data on ventricular electrical remodelling following closure, particularly regarding closure technique, remain limited. Objectıve: To evaluate ventricular depolarisation and repolarisation indices in children with isolated ventricular septal defects before and after closure and to compare the outcomes of surgical and transcatheter approaches. Methods: This retrospective, single-centre study included 58 children aged 4–18 months who underwent isolated ventricular septal defect closure (transcatheter, n = 25; surgical, n = 33) and 40 age- and sex-matched healthy controls. Standard 12-lead electrocardiograms recorded before the procedure and at six months after closure were analysed. Multiple ventricular depolarisation and repolarisation indices were assessed. Results: Before closure, children with ventricular septal defects demonstrated significant abnormalities in ventricular depolarisation and repolarisation indices compared with healthy controls (all p < 0.05). Following closure, most repolarisation indices improved in both groups. Improvement was more pronounced after transcatheter closure, whereas QT interval and QT dispersion did not significantly improve following surgical closure. At the six-month follow-up, QRS duration remained significantly longer in both interventions than in controls. Conclusion: Children with isolated ventricular septal defects demonstrate subclinical alterations in ventricular depolarisation and repolarisation. Defect closure is associated with substantial improvement in ventricular repolarisation; however, depolarisation abnormalities may persist during mid-term follow-up irrespective of closure technique.
- 23 February 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (2) , 294-305
Individualised interventional strategies and clinical outcomes in paediatric patients with pulmonary arterial hypertension
Objective: This study evaluated the safety and efficacy of individualised interventional strategies in paediatric pulmonary arterial hypertension, focusing on the outcomes of atrial septostomy, reverse Potts shunt, and partial ASD closure in patients unresponsive to medical therapy or with rapid right ventricular deterioration. Methods: A retrospective analysis included 12 paediatric patients who underwent 18 interventional procedures between 2019 and 2024. Pulmonary arterial hypertension was confirmed by right heart catheterisation, and pre- and post-procedural clinical, echocardiographic, and haemodynamic data were compared. Results: Interventions included graded balloon atrial septostomy ( n = 10), partial ASD closure ( n = 2), and reverse Potts shunt via ductal stenting ( n = 1). All surviving patients showed clinical improvement with significant reductions in heart rate ( p < 0.01), NT-proBNP ( p = 0.008), mean right atrial pressure ( p < 0.001), and RV/LV end-diastolic diameter ratio ( p = 0.014), along with improvements in six-minute walk distance ( p = 0.002), WHO functional class ( p < 0.001), and TAPSE ( p = 0.028). One patient (8.3%) died within days following atrial septostomy due to nonadherence to medical therapy. Three patients required repeat atrial septostomy because of shunt restriction or spontaneous narrowing. Conclusion: Individualised interventional strategies guided by comprehensive haemodynamic assessment can slow disease progression and improve quality of life in paediatric pulmonary arterial hypertension. Partial ASD closure, as a novel approach in this cohort, reduces excessive left-to-right volume load while preserving a controlled right-to-left shunt, thereby enhancing haemodynamic stability and optimising outcomes. Timely implementation of interventional strategies before disease progression may help reduce mortality.
- 23 February 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (2) , 294-305
Individualised interventional strategies and clinical outcomes in paediatric patients with pulmonary arterial hypertension
Objective: This study evaluated the safety and efficacy of individualised interventional strategies in paediatric pulmonary arterial hypertension, focusing on the outcomes of atrial septostomy, reverse Potts shunt, and partial ASD closure in patients unresponsive to medical therapy or with rapid right ventricular deterioration. Methods: A retrospective analysis included 12 paediatric patients who underwent 18 interventional procedures between 2019 and 2024. Pulmonary arterial hypertension was confirmed by right heart catheterisation, and pre- and post-procedural clinical, echocardiographic, and haemodynamic data were compared. Results: Interventions included graded balloon atrial septostomy ( n = 10), partial ASD closure ( n = 2), and reverse Potts shunt via ductal stenting ( n = 1). All surviving patients showed clinical improvement with significant reductions in heart rate ( p < 0.01), NT-proBNP ( p = 0.008), mean right atrial pressure ( p < 0.001), and RV/LV end-diastolic diameter ratio ( p = 0.014), along with improvements in six-minute walk distance ( p = 0.002), WHO functional class ( p < 0.001), and TAPSE ( p = 0.028). One patient (8.3%) died within days following atrial septostomy due to nonadherence to medical therapy. Three patients required repeat atrial septostomy because of shunt restriction or spontaneous narrowing. Conclusion: Individualised interventional strategies guided by comprehensive haemodynamic assessment can slow disease progression and improve quality of life in paediatric pulmonary arterial hypertension. Partial ASD closure, as a novel approach in this cohort, reduces excessive left-to-right volume load while preserving a controlled right-to-left shunt, thereby enhancing haemodynamic stability and optimising outcomes. Timely implementation of interventional strategies before disease progression may help reduce mortality.
- 11 December 2025
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 35 (12) , 2598-2601
ECG artefact or life-threatening arrhythmia? A neonatal presentation of Long QT syndrome type 3 with a de novo SCN5A mutation
Electrocardiogram interpretation is critical in neonatal care, as artefacts may mimic life-threatening arrhythmias. We report the case of a preterm newborn girl, delivered at 31 weeks of gestation due to acute fetal distress, who developed tachycardia shortly after birth. The initial ECG showed chaotic electrical activity, initially raising suspicion of artifact; however, a subsequent tracing confirmed a life-threatening arrhythmia with wide QRS complexes, prolonged QTc, and torsades de pointes. As the patient remained haemodynamically stable, intravenous lidocaine and magnesium sulphate were administered, achieving pharmacological cardioversion. Propranolol was subsequently initiated, and the lidocaine infusion was tapered and replaced with oral mexiletine. Serial electrocardiograms showed QTc interval improvement, left ventricular function normalised, and the patient was discharged on the 39th postnatal day following stabilisation and supportive care for prematurity. Genetic testing identified a de novo SCN5A c.796C > G (p.L266V) mutation associated with Long QT syndrome type 3. At 1 year of age, the patient remains stable and asymptomatic while receiving combined therapy with propranolol and mexiletine.
- 11 December 2025
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 35 (12) , 2598-2601
ECG artefact or life-threatening arrhythmia? A neonatal presentation of Long QT syndrome type 3 with a de novo SCN5A mutation
Electrocardiogram interpretation is critical in neonatal care, as artefacts may mimic life-threatening arrhythmias. We report the case of a preterm newborn girl, delivered at 31 weeks of gestation due to acute fetal distress, who developed tachycardia shortly after birth. The initial ECG showed chaotic electrical activity, initially raising suspicion of artifact; however, a subsequent tracing confirmed a life-threatening arrhythmia with wide QRS complexes, prolonged QTc, and torsades de pointes. As the patient remained haemodynamically stable, intravenous lidocaine and magnesium sulphate were administered, achieving pharmacological cardioversion. Propranolol was subsequently initiated, and the lidocaine infusion was tapered and replaced with oral mexiletine. Serial electrocardiograms showed QTc interval improvement, left ventricular function normalised, and the patient was discharged on the 39th postnatal day following stabilisation and supportive care for prematurity. Genetic testing identified a de novo SCN5A c.796C > G (p.L266V) mutation associated with Long QT syndrome type 3. At 1 year of age, the patient remains stable and asymptomatic while receiving combined therapy with propranolol and mexiletine.
- 7 November 2025
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 48 (12) , 1362-1367
Comparison of 6‐mm and 8‐mm Tip Cryoablation Catheters in the Treatment of Pediatric AVNRT
Background: Radiofrequency (RF) ablation has long been the standard treatment for atrioventricular nodal reentrant tachycardia (AVNRT) in children. However, cryoablation (CA) has gained popularity due to its safety profile and acceptable long‐term success rates. Comparative data on different CA catheter tip sizes in pediatric AVNRT are limited. Objective: To compare the acute and long‐term outcomes of 6‐mm vs. 8‐mm tip CA catheters in pediatric patients undergoing AVNRT ablation. Methods and Results: This retrospective single‐center study included 129 pediatric patients (76 female, mean age 13 ± 3.0 years, mean weight 51.7 ± 15.7 kg) who underwent CA for AVNRT between January 2016 and December 2022. A 6‐mm tip catheter was used in 64 patients and an 8‐mm tip catheter in 65 patients. All procedures were performed using a three‐dimensional electroanatomical mapping system (EAMS) (EnSite, Abbott/St. Jude Medical Inc., St. Paul, MN, USA), with minimal or no fluoroscopy in most cases. Acute success, recurrence rates, procedural parameters, and complications were compared between groups. Of the 129 patients, 126 (97.7%) had typical AVNRT and 3 (2.3%) had atypical AVNRT. The mean procedure time was 151.9 ± 43 min, with no significant difference between groups. Acute success rates were 100% in the 6‐mm group and 98.5% in the 8‐mm group ( p > 0.05). The mean number of cryolesions was 8.5 ± 2.3 (6‐mm) and 9.0 ± 2.5 (8‐mm) ( p > 0.05). Over a mean follow‐up of 31.4 ± 26 months, recurrences occurred in six patients (4.6%), all successfully re‐ablated. Long‐term success rates were 94.4% overall, with no significant difference between groups. No permanent complications occurred; transient AV block was observed in one patient (0.7%). Conclusions: Both 6‐mm and 8‐mm CA catheters achieve high acute success and low recurrence rates in pediatric AVNRT with similar safety profiles. Catheter tip size can be tailored to patient age and weight without compromising efficacy. Minimal fluoroscopy approaches can be applied safely in the majority of cases.
- 7 November 2025
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 48 (12) , 1362-1367
Comparison of 6‐mm and 8‐mm Tip Cryoablation Catheters in the Treatment of Pediatric AVNRT
Background: Radiofrequency (RF) ablation has long been the standard treatment for atrioventricular nodal reentrant tachycardia (AVNRT) in children. However, cryoablation (CA) has gained popularity due to its safety profile and acceptable long‐term success rates. Comparative data on different CA catheter tip sizes in pediatric AVNRT are limited. Objective: To compare the acute and long‐term outcomes of 6‐mm vs. 8‐mm tip CA catheters in pediatric patients undergoing AVNRT ablation. Methods and Results: This retrospective single‐center study included 129 pediatric patients (76 female, mean age 13 ± 3.0 years, mean weight 51.7 ± 15.7 kg) who underwent CA for AVNRT between January 2016 and December 2022. A 6‐mm tip catheter was used in 64 patients and an 8‐mm tip catheter in 65 patients. All procedures were performed using a three‐dimensional electroanatomical mapping system (EAMS) (EnSite, Abbott/St. Jude Medical Inc., St. Paul, MN, USA), with minimal or no fluoroscopy in most cases. Acute success, recurrence rates, procedural parameters, and complications were compared between groups. Of the 129 patients, 126 (97.7%) had typical AVNRT and 3 (2.3%) had atypical AVNRT. The mean procedure time was 151.9 ± 43 min, with no significant difference between groups. Acute success rates were 100% in the 6‐mm group and 98.5% in the 8‐mm group ( p > 0.05). The mean number of cryolesions was 8.5 ± 2.3 (6‐mm) and 9.0 ± 2.5 (8‐mm) ( p > 0.05). Over a mean follow‐up of 31.4 ± 26 months, recurrences occurred in six patients (4.6%), all successfully re‐ablated. Long‐term success rates were 94.4% overall, with no significant difference between groups. No permanent complications occurred; transient AV block was observed in one patient (0.7%). Conclusions: Both 6‐mm and 8‐mm CA catheters achieve high acute success and low recurrence rates in pediatric AVNRT with similar safety profiles. Catheter tip size can be tailored to patient age and weight without compromising efficacy. Minimal fluoroscopy approaches can be applied safely in the majority of cases.
- Open Access
- 3 November 2025
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 60 (6) , 676-682
Can Peripheral Venous Oxygen Saturation Predict Clinical Decompensation in Pediatric Dilated Cardiomyopathy?
Objective: Children diagnosed with dilated cardiomyopathy (DCM) frequently require hospitalization due to episodes of decompensated heart failure. Impaired oxygen utilization is a hallmark of decompensated heart failure, and peripheral venous oxygen saturation (SpvO2) may serve as a useful indirect marker of the mismatch between oxygen delivery and tissue demand. This study aims to evaluate the predictive value of SpvO₂ in identifying clinical decompensation and mortality in pediatric DCM patients. Materials and Methods: A retrospective review was conducted on 55 pediatric patients diagnosed with DCM from January 2019 to September 2023. Blood gas parameters (pH, SpvO2, lactate, and bicarbonate) obtained from peripheral venous samples, along with laboratory parameters such as N-terminal pro-B-type natriuretic peptide and echocardiographic measurements including left ventricular ejection fraction (EF) and fractional shortening, were recorded. Patients were categorized into stable and unstable (decompensated) groups based on their clinical status, admission type, modified Ross score (ages 1-5), and New York Heart Association classification (ages >5). Results: Left ventricular EF and SpvO2 were significantly lower, while N-terminal pro-B-type natriuretic peptide was significantly higher in children with decompensated heart failure. A SpvO2 cut-off value of 60.7% demonstrated 90% sensitivity and 85% specificity, demonstrating its strong predictive value for decompensation in pediatric DCM. Patients with SpvO2 ≤ 60.7% had a significantly higher mortality rate during the 12-month follow-up period (P = .031), primarily driven by increased mortality within the first 3 months (P = .035). However, no significant association between SpO2 levels and mortality was observed beyond 3 months (P = .846) Conclusion: Peripheral venous oxygen saturation is a valuable parameter for predicting both decompensated heart failure and mortality in children with DCM, complementing clinical and laboratory findings. Cite this article as: Şahan Y., Torun EG, Ece İ, .etin İİ. Can peripheral venous oxygen saturation predict clinical decompensation in pediatric dilated cardiomyopathy?. Turk Arch Pediatr. 2025;60(6):676-682.
- 3 November 2025
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 60 (6) , 676-682
Open AccessCan Peripheral Venous Oxygen Saturation Predict Clinical Decompensation in Pediatric Dilated Cardiomyopathy?
Objective: Children diagnosed with dilated cardiomyopathy (DCM) frequently require hospitalization due to episodes of decompensated heart failure. Impaired oxygen utilization is a hallmark of decompensated heart failure, and peripheral venous oxygen saturation (SpvO2) may serve as a useful indirect marker of the mismatch between oxygen delivery and tissue demand. This study aims to evaluate the predictive value of SpvO₂ in identifying clinical decompensation and mortality in pediatric DCM patients. Materials and Methods: A retrospective review was conducted on 55 pediatric patients diagnosed with DCM from January 2019 to September 2023. Blood gas parameters (pH, SpvO2, lactate, and bicarbonate) obtained from peripheral venous samples, along with laboratory parameters such as N-terminal pro-B-type natriuretic peptide and echocardiographic measurements including left ventricular ejection fraction (EF) and fractional shortening, were recorded. Patients were categorized into stable and unstable (decompensated) groups based on their clinical status, admission type, modified Ross score (ages 1-5), and New York Heart Association classification (ages >5). Results: Left ventricular EF and SpvO2 were significantly lower, while N-terminal pro-B-type natriuretic peptide was significantly higher in children with decompensated heart failure. A SpvO2 cut-off value of 60.7% demonstrated 90% sensitivity and 85% specificity, demonstrating its strong predictive value for decompensation in pediatric DCM. Patients with SpvO2 ≤ 60.7% had a significantly higher mortality rate during the 12-month follow-up period (P = .031), primarily driven by increased mortality within the first 3 months (P = .035). However, no significant association between SpO2 levels and mortality was observed beyond 3 months (P = .846) Conclusion: Peripheral venous oxygen saturation is a valuable parameter for predicting both decompensated heart failure and mortality in children with DCM, complementing clinical and laboratory findings. Cite this article as: Şahan Y., Torun EG, Ece İ, .etin İİ. Can peripheral venous oxygen saturation predict clinical decompensation in pediatric dilated cardiomyopathy?. Turk Arch Pediatr. 2025;60(6):676-682.
- 18 August 2025
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- p. 1-4
Life-saving stepwise management of pulmonary hypertension in an infant with Down syndrome presenting with a large patent ductus arteriosus and giant hepatic arteriovenous malformation
We report a rare case of a 3-month-old male infant with Down syndrome, severe pulmonary arterial hypertension (a large patent ductus arteriosus, an atrial septal defect, and a giant hepatic arteriovenous malformation). Initial treatment involved hepatic arteriovenous malformation embolisation using 17 Azur® CX Peripheral Coils, resulting in clinical improvement. However, persistent pulmonary arterial hypertension led to patent ductus arteriosus closure using an 8-mm Lifetech Cera™ vascular plug after a successful balloon occlusion test. Post-intervention, the patient showed symptomatic relief, reduced right ventricular overload, and atrial septal defect shunting shifted to left to right. This is the first reported paediatric case combining these features successfully managed through a multidisciplinary and stepwise treatment approach, eliminating the need for liver transplantation.
- 18 August 2025
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- p. 1-4
Life-saving stepwise management of pulmonary hypertension in an infant with Down syndrome presenting with a large patent ductus arteriosus and giant hepatic arteriovenous malformation
We report a rare case of a 3-month-old male infant with Down syndrome, severe pulmonary arterial hypertension (a large patent ductus arteriosus, an atrial septal defect, and a giant hepatic arteriovenous malformation). Initial treatment involved hepatic arteriovenous malformation embolisation using 17 Azur® CX Peripheral Coils, resulting in clinical improvement. However, persistent pulmonary arterial hypertension led to patent ductus arteriosus closure using an 8-mm Lifetech Cera™ vascular plug after a successful balloon occlusion test. Post-intervention, the patient showed symptomatic relief, reduced right ventricular overload, and atrial septal defect shunting shifted to left to right. This is the first reported paediatric case combining these features successfully managed through a multidisciplinary and stepwise treatment approach, eliminating the need for liver transplantation.
- 25 July 2025
- Published by Springer Nature in Pediatric Cardiology
- Vol. 47 (4) , 1788-1797
Pulmonary Artery Pulsatility Index: A Novel Marker for Risk Assessment and Prognosis in Pediatric Idiopathic Pulmonary Arterial Hypertension
The pulmonary artery pulsatility index (PAPi), calculated as (systolic pulmonary artery pressure - diastolic pulmonary artery pressure)/mean right atrial pressure). This study aimed to assess the clinical utility of PAPi in risk stratification for pediatric idiopathic pulmonary arterial hypertension (IPAH) and its performance in predicting the need for invasive intervention due to severe right heart failure. We analyzed clinical, echocardiographic, and right heart catheterization findings of 24 IPAH patients between April 2019 and November 2024. Statistical analyses included ROC curve analysis for PAPi's diagnostic performance, Kaplan-Meier survival analysis, and Cox regression for identifying independent predictors of intervention. The study included 24 patients (mean age 8.2 ± 4.7 years, 66.7% female). Based on pediatric risk classification, 45.8% were lower-risk, and 54.2% were high-risk, with PAPi significantly lower in high-risk patients (p < 0.001). ROC analysis identified PAPi < 3.24 as a strong predictor of high-risk status (sensitivity = 92%, specificity = 82%). PAPi correlated positively with 6MWT (r = 0.802) and TAPSE (r = 0.812) and negatively with WHO-FC (r = - 0.692) and NT-proBNP (r = - 0.713) (p < 0.001). Over 22 ± 15.9 months, 37.5% (n = 9) required invasive interventions for syncope, WHO-FC III/IV symptoms, or right ventricular failure, including atrial septostomy (77.8%), partial ASD closure (11.1%), and reverse Potts shunt (11.1%). Post-intervention, all but one patient improved. Patients requiring intervention had lower PAPi (1.88 ± 0.71 vs. 3.95 ± 1.27, p < 0.001). Kaplan-Meier analysis confirmed PAPi > 3.24 was associated with longer event-free survival (p = 0.002). Cox regression showed higher PAPi independently predicted lower intervention risk (HR 0.36, p = 0.042). In conclusion, this study suggests that PAPi is a reliable prognostic marker for risk stratification and predicting the need for invasive intervention in pediatric IPAH.
- 25 July 2025
- Published by Springer Nature in Pediatric Cardiology
- Vol. 47 (4) , 1788-1797
Pulmonary Artery Pulsatility Index: A Novel Marker for Risk Assessment and Prognosis in Pediatric Idiopathic Pulmonary Arterial Hypertension
The pulmonary artery pulsatility index (PAPi), calculated as (systolic pulmonary artery pressure - diastolic pulmonary artery pressure)/mean right atrial pressure). This study aimed to assess the clinical utility of PAPi in risk stratification for pediatric idiopathic pulmonary arterial hypertension (IPAH) and its performance in predicting the need for invasive intervention due to severe right heart failure. We analyzed clinical, echocardiographic, and right heart catheterization findings of 24 IPAH patients between April 2019 and November 2024. Statistical analyses included ROC curve analysis for PAPi's diagnostic performance, Kaplan-Meier survival analysis, and Cox regression for identifying independent predictors of intervention. The study included 24 patients (mean age 8.2 ± 4.7 years, 66.7% female). Based on pediatric risk classification, 45.8% were lower-risk, and 54.2% were high-risk, with PAPi significantly lower in high-risk patients (p < 0.001). ROC analysis identified PAPi < 3.24 as a strong predictor of high-risk status (sensitivity = 92%, specificity = 82%). PAPi correlated positively with 6MWT (r = 0.802) and TAPSE (r = 0.812) and negatively with WHO-FC (r = - 0.692) and NT-proBNP (r = - 0.713) (p < 0.001). Over 22 ± 15.9 months, 37.5% (n = 9) required invasive interventions for syncope, WHO-FC III/IV symptoms, or right ventricular failure, including atrial septostomy (77.8%), partial ASD closure (11.1%), and reverse Potts shunt (11.1%). Post-intervention, all but one patient improved. Patients requiring intervention had lower PAPi (1.88 ± 0.71 vs. 3.95 ± 1.27, p < 0.001). Kaplan-Meier analysis confirmed PAPi > 3.24 was associated with longer event-free survival (p = 0.002). Cox regression showed higher PAPi independently predicted lower intervention risk (HR 0.36, p = 0.042). In conclusion, this study suggests that PAPi is a reliable prognostic marker for risk stratification and predicting the need for invasive intervention in pediatric IPAH.
- Open Access
- 2 May 2025
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 60 (3) , 274-279
Neonatologist-Performed Echocardiography versus Pediatric Cardiologist for the Patent Ductus Arteriosus in Preterm Newborns
Objective: Premature babies have a fragile circulatory system balance; therefore, rapid intervention may be needed in patients with patent ductus arteriosus (PDA). Echocardiography performed by a neonatologist can help to choose the best treatment option for newborns in a timely manner. The aim is to evaluate the performance of neonatologists in ductus assessment. Materials and Methods: Among the neonates born at the hospital, those diagnosed with PDA (n = 40) under 32 weeks of gestational age were evaluated with echocardiography by a neonatologist and a pediatric cardiologist. Interobserver variability analysis was done using the intraclass coefficient value and Cohen’s kappa test results. Results: An excellent interobserver agreement was found in the peak systolic-to-end diastolic flow velocity ratio, a good agreement in the narrowest diameter of the ductus, peak systolic and diastolic velocities, and mitral A velocity. Raters had moderate to poor agreement in the rest of the variables such as left atrium/aorta ratio, ampulla diameter, length of the ductus, and left pulmonary artery diameter. Conclusion: It is suggested that neonatologists perform echocardiography to measure the narrowest diameter of the ductus and ductal flow velocities for PDA evaluation. Cite this article as: Beyazal M, Hosagasi NH, Torun EG, Bagrul D, Kurt A. Neonatologist-performed echocardiography versus pediatric cardiologist for the patent ductus arteriosus in preterm newborns. Turk Arch Pediatr. 2025;60(3):274-279.
- 2 May 2025
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 60 (3) , 274-279
Open AccessNeonatologist-Performed Echocardiography versus Pediatric Cardiologist for the Patent Ductus Arteriosus in Preterm Newborns
Objective: Premature babies have a fragile circulatory system balance; therefore, rapid intervention may be needed in patients with patent ductus arteriosus (PDA). Echocardiography performed by a neonatologist can help to choose the best treatment option for newborns in a timely manner. The aim is to evaluate the performance of neonatologists in ductus assessment. Materials and Methods: Among the neonates born at the hospital, those diagnosed with PDA (n = 40) under 32 weeks of gestational age were evaluated with echocardiography by a neonatologist and a pediatric cardiologist. Interobserver variability analysis was done using the intraclass coefficient value and Cohen’s kappa test results. Results: An excellent interobserver agreement was found in the peak systolic-to-end diastolic flow velocity ratio, a good agreement in the narrowest diameter of the ductus, peak systolic and diastolic velocities, and mitral A velocity. Raters had moderate to poor agreement in the rest of the variables such as left atrium/aorta ratio, ampulla diameter, length of the ductus, and left pulmonary artery diameter. Conclusion: It is suggested that neonatologists perform echocardiography to measure the narrowest diameter of the ductus and ductal flow velocities for PDA evaluation. Cite this article as: Beyazal M, Hosagasi NH, Torun EG, Bagrul D, Kurt A. Neonatologist-performed echocardiography versus pediatric cardiologist for the patent ductus arteriosus in preterm newborns. Turk Arch Pediatr. 2025;60(3):274-279.